Company intelligence / Profile preview

Famar

Ownership: Private
Development stage: Commercial

Overview

Famar is a leading European CDMO with over 75 years of experience in pharmaceutical development and manufacturing. The company operates six production facilities across Greece, Italy, and Spain and two R&D centers. It supplies more than 1,800 products—including prescription drugs (Rx), over-the-counter (OTC) medicines, generics, and health & beauty products—in various dosage forms to 80 international markets.

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Famar works with many leading global pharmaceutical companies as contract partners

Beyond the preview

Go deeper on Famar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Famar.

Explore the full profile